{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T14:08:05Z","timestamp":1768399685197,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2007,1,9]],"date-time":"2007-01-09T00:00:00Z","timestamp":1168300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,1,9]],"date-time":"2007-01-09T00:00:00Z","timestamp":1168300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1007\/s10067-006-0503-z","type":"journal-article","created":{"date-parts":[[2007,1,8]],"date-time":"2007-01-08T14:54:36Z","timestamp":1168268076000},"page":"1299-1305","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["T helper 1 type cytokines polymorphisms: association with susceptibility to Beh\u00e7et\u2019s disease"],"prefix":"10.1007","volume":"26","author":[{"given":"Gamze","family":"Alayl\u0131","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Y\u0131lmaz","family":"\u00c7oban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y\u00fcksel","family":"S\u00fcll\u00fc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferhan","family":"Cant\u00fcrk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y\u00fcksel","family":"Bek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belma","family":"Durup\u0131nar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tayyar","family":"Cant\u00fcrk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,1,9]]},"reference":[{"key":"503_CR1","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane T, Takeno M, Suzuki N et al (1999) Behcet\u2019s disease. N Engl J Med 341:1284\u20131291","journal-title":"N Engl J Med"},{"key":"503_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.coph.2003.10.009","volume":"4","author":"T Arayssi","year":"2004","unstructured":"Arayssi T, Hamdan A (2004) New insights into the pathogenesis and therapy of Behcet\u2019s disease. Curr Opin Pharmacol 4:183\u2013188","journal-title":"Curr Opin Pharmacol"},{"issue":"Suppl. 24","key":"503_CR3","first-page":"S6","volume":"19","author":"A Gul","year":"2001","unstructured":"Gul A (2001) Behc\u00e7et\u2019s disease: an update on the pathogenesis. Clin Exp Rheumatol 19(Suppl. 24):S6\u2013S12","journal-title":"Clin Exp Rheumatol"},{"key":"503_CR4","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/art.1780251110","volume":"25","author":"T Sakane","year":"1982","unstructured":"Sakane T, Kotani H, Takada S et al (1982) Functional aberration of T cell subsets in patients with Beh\u00e7et\u2019s disease. Arthritis Rheum 25:1343\u20131351","journal-title":"Arthritis Rheum"},{"key":"503_CR5","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1136\/ard.60.11.996","volume":"60","author":"H Direskeneli","year":"2001","unstructured":"Direskeneli H (2001) Behcet\u2019s disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 60:996\u20131002","journal-title":"Ann Rheum Dis"},{"key":"503_CR6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5021\/ad.1993.5.2.69","volume":"5","author":"W Lew","year":"1993","unstructured":"Lew W, Lee SH, Bang D et al (1993) Serum tumor necrosis factor, interleukin-1-beta and interleukin-6 levels in Beh\u00e7et\u2019s disease. Ann Dermatol 5:69\u201373","journal-title":"Ann Dermatol"},{"key":"503_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/030097402320318387","volume":"31","author":"K Hamzaoui","year":"2002","unstructured":"Hamzaoui K, Hamzaoui A, Guemira F et al (2002) Cytokine profile in Behcet\u2019s disease patients. Relationship with disease activity. Scand J Rheumatol 31:205\u2013210","journal-title":"Scand J Rheumatol"},{"key":"503_CR8","first-page":"1078","volume":"335","author":"International Study Group for Behcet\u2019s Disease","year":"1990","unstructured":"International Study Group for Behcet\u2019s Disease (1990) Criteria for diagnosis of Behcet\u2019s disease. Lancet 335:1078\u20131080","journal-title":"Lancet"},{"key":"503_CR9","first-page":"321","volume":"23","author":"N Sayinalp","year":"1996","unstructured":"Sayinalp N, Ozcebe OI, Ozdemir O et al (1996) Cytokines in Behcet\u2019s disease. J Rheumatol 23:321\u2013322","journal-title":"J Rheumatol"},{"key":"503_CR10","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1046\/j.1365-2141.2003.04314.x","volume":"121","author":"ML MacMillan","year":"2003","unstructured":"MacMillan ML, Radloff GA, DeFor TE et al (2003) Interleukin-1 genotype and outcome of unrelated donor bone marrow transplantation. Br J Haematol 121:597\u2013604","journal-title":"Br J Haematol"},{"key":"503_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/rheumatology\/keg443","volume":"43","author":"JS Ravindran","year":"2004","unstructured":"Ravindran JS, Owen P, Lagan A et al (2004) Interleukin 1 alpha, interleukin 1beta and interleukin 1 receptor gene polymorphisms in psoriatic arthritis. Rheumatology (Oxford) 43:22\u201326","journal-title":"Rheumatology (Oxford)"},{"key":"503_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/ard.2003.007336","volume":"63","author":"CG Parks","year":"2004","unstructured":"Parks CG, Cooper GS, Dooley MA et al (2004) Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population based study in the southeastern United States. Ann Rheum Dis 63:91\u201394","journal-title":"Ann Rheum Dis"},{"key":"503_CR13","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/rheumatology\/keg232R","volume":"42","author":"J Karasneh","year":"2003","unstructured":"Karasneh J, Hajeer AH, Barrett J et al (2003) Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet\u2019s disease. Rheumatology (Oxford) 42:860\u2013864","journal-title":"Rheumatology (Oxford)"},{"key":"503_CR14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.0906-6705.2005.00253.x","volume":"14","author":"M Coskun","year":"2005","unstructured":"Coskun M, Bacanli A, Sallakci N et al (2005) Specific interleukin-1 gene polymorphisms in Turkish patients with Behcet\u2019s disease. Exp Dermatol 14:124\u2013129","journal-title":"Exp Dermatol"},{"key":"503_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1046\/j.1365-3083.1998.00300.x","volume":"47","author":"S Santtila","year":"1998","unstructured":"Santtila S, Savinainen K, Hurme M (1998) Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 47:195\u2013198","journal-title":"Scand J Immunol"},{"key":"503_CR16","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s002510050530","volume":"49","author":"A Nemetz","year":"1999","unstructured":"Nemetz A, Nosti-Escanilla MP, Molnar T et al (1999) IL-1B gene polymorphisms influence the course and severity of inflammatory bowel disease. Immunogenetics 49:527\u2013531","journal-title":"Immunogenetics"},{"key":"503_CR17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1161\/01.ATV.0000150039.60906.02","volume":"25","author":"L Iacoviello","year":"2005","unstructured":"Iacoviello L, Di Castelnuovo A, Gattone M et al (2005) Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol 25:222\u2013227","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"503_CR18","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1034\/j.1600-051X.2002.290701.x","volume":"29","author":"RM Scarel-Caminaga","year":"2002","unstructured":"Scarel-Caminaga RM, Trevilatto PC, Souza AP et al (2002) Investigation of an IL-2 polymorphism in patients with different levels of chronic periodontitis. J Clin Periodontol 29:587\u2013591","journal-title":"J Clin Periodontol"},{"key":"503_CR19","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1046\/j.1365-2370.1998.00139.x","volume":"25","author":"S John","year":"1998","unstructured":"John S, Turner D, Donn R et al (1998) Two novel biallelic polymorphisms in the IL-2 gene. Eur J Immunogenet 25:419\u2013420","journal-title":"Eur J Immunogenet"},{"key":"503_CR20","first-page":"159","volume":"23","author":"A Pawlik","year":"2005","unstructured":"Pawlik A, Kurzawski M, Florczak M et al (2005) IL1beta+3953 exon 5 and IL-2 \u2212330 promoter polymorphisms in patients with rheumatoid arthritis. Clin Exp Rheumatol 23:159\u2013164","journal-title":"Clin Exp Rheumatol"},{"key":"503_CR21","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/1529-0131(199909)42:9<1967::AID-ANR24>3.0.CO;2-Z","volume":"42","author":"MA Frassanito","year":"1999","unstructured":"Frassanito MA, Dammacco R, Cafforio P, Dammacco F (1999) Th1 polarization of the immune response in Behcet\u2019s disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum 42:1967\u20131974","journal-title":"Arthritis Rheum"},{"key":"503_CR22","first-page":"329","volume":"25","author":"S Raziuddin","year":"1998","unstructured":"Raziuddin S, al-Dalaan A, Bahabri S et al (1998) Divergent cytokine production profile in Behcet\u2019s disease. Altered Th1\/Th2 cell cytokine pattern. J Rheumatol 25:329\u2013333","journal-title":"J Rheumatol"},{"key":"503_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/sj.gene.6363661","volume":"1","author":"MA Hall","year":"2000","unstructured":"Hall MA, McGlinn E, Coakley G et al (2000) Genetic polymorphism of IL-12 p40 gene in immune-mediated disease. Genes Immun 1:219\u2013224","journal-title":"Genes Immun"},{"key":"503_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1465-9921-4-6","volume":"4","author":"P Latsi","year":"2003","unstructured":"Latsi P, Pantelidis P, Vassilakis D et al (2003) Analysis of IL-12 p40 subunit gene and IFN-gamma G5644A polymorphisms in idiopathic pulmonary fibrosis. Respir Res 4:6","journal-title":"Respir Res"},{"key":"503_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/ana.1107","volume":"50","author":"T van Veen","year":"2001","unstructured":"van Veen T, Crusius JB, Schrijver HM et al (2001) Interleukin-12p40 genotype plays a role in the susceptibility to multiple sclerosis. Ann Neur 50:275","journal-title":"Ann Neur"},{"key":"503_CR26","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/84872","volume":"27","author":"G Morahan","year":"2001","unstructured":"Morahan G, Huang D, Ymer SI et al (2001) Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat Genet 27:218\u2013221","journal-title":"Nat Genet"},{"key":"503_CR27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jdermsci.2003.12.004","volume":"342","author":"H Yanagihori","year":"2004","unstructured":"Yanagihori H, Tojo M, Inoue T et al (2004) Lack of association of interleukin-12 p40 gene (IL12B) polymorphism with Behcet\u2019s disease in the Japanese population. J Dermatol Sci 342:112\u2013114","journal-title":"J Dermatol Sci"},{"key":"503_CR28","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/sj.jid.5700203","volume":"126","author":"H Yanagihori","year":"2006","unstructured":"Yanagihori H, Oyama N, Nakamura K et al (2006) Role of IL-12B promoter polymorphism in Adamantiades\u2013Behcet\u2019s disease susceptibility: an involvement of Th1 immunoreactivity against Streptococcus Sanguinis antigen. Invest Dermatol 126:1534\u20131540","journal-title":"Invest Dermatol"},{"key":"503_CR29","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/sj.gene.6363919","volume":"3","author":"D Seegers","year":"2002","unstructured":"Seegers D, Zwiers A, Strober W et al (2002) A Taql polymorphism in the 3\u2032UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun 3:419\u2013423","journal-title":"Genes Immun"},{"key":"503_CR30","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1378\/chest.118.2.503","volume":"118","author":"CA Dinarello","year":"2000","unstructured":"Dinarello CA (2000) Proinflammatory cytokines. Chest 118:503\u2013508","journal-title":"Chest"},{"key":"503_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0165-5728(96)00182-8","volume":"72","author":"TW Huizinga","year":"1997","unstructured":"Huizinga TW, Westendorp RG, Bollen EL et al (1997) TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol 72:149\u2013153","journal-title":"J Neuroimmunol"},{"key":"503_CR32","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1365-3083.1995.tb03686.x","volume":"42","author":"F Pociot","year":"1995","unstructured":"Pociot F, D\u2019Alfonso A, Compasso S et al (1995) Functional analysis of a new polymorphism in the human TNF alpha gene promoter. Scand J Immunol 42:501\u2013504","journal-title":"Scand J Immunol"},{"key":"503_CR33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s002510050320","volume":"47","author":"T Weissensteiner","year":"1997","unstructured":"Weissensteiner T, Lanchbury JS (1997) TNFB polymorphisms characterize three lineages of TNF region microsatellite haplotypes. Immunogenetics 47:6\u201316","journal-title":"Immunogenetics"},{"key":"503_CR34","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0198-8859(03)00057-0","volume":"64","author":"EB Lee","year":"2003","unstructured":"Lee EB, Kim JY, Lee YJ et al (2003) TNF and TNF receptor polymorphisms in Korean Behcet\u2019s disease patients. Hum Immunol 64:614\u2013620","journal-title":"Hum Immunol"},{"key":"503_CR35","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/art.10815","volume":"48","author":"T Ahmad","year":"2003","unstructured":"Ahmad T, Wallace GR, James T et al (2003) Mapping the HLA association in Behcet\u2019s disease: a role for tumor necrosis factor polymorphisms? Arthritis Rheum 48:807\u2013813","journal-title":"Arthritis Rheum"},{"key":"503_CR36","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1365-2133.2006.07348.x","volume":"155","author":"A Akman","year":"2006","unstructured":"Akman A, Sallakci N, Coskun M et al (2006) TNF-alpha gene 1031\u00a0T\/C polymorphism in Turkish patients with Behcet\u2019s disease. Br J Dermatol 155:350\u2013356","journal-title":"Br J Dermatol"},{"key":"503_CR37","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s00296-005-0610-1","volume":"26","author":"A Ates","year":"2006","unstructured":"Ates A, Kinikli G, Duzgun N et al (2006) Lack of association of tumor necrosis factor-alpha gene polymorphisms with disease susceptibility and severity in Beh\u00e7et\u2019s disease. Rheumatol Int 26:348\u2013353","journal-title":"Rheumatol Int"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-006-0503-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-006-0503-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-006-0503-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-006-0503-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T02:34:36Z","timestamp":1652582076000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-006-0503-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,9]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["503"],"URL":"https:\/\/doi.org\/10.1007\/s10067-006-0503-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,9]]},"assertion":[{"value":"19 October 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}